Whereas, a few years ago DNA information was considered 'scary', nowadays it is accepted as relevant information for human optimization. Genetic testing is becoming increasingly available to the public via commercial applications which provide tools for DNA-based decision making. The research team Consumer Genetics investigates the issues around direct-to-consumer genetics that are in current debate. It translates its results to market, via de university spin-off MyBasePair at Brightlands, Maastricht Health Campus. In addition, it continuously summarizes all scientific studies on the relation between DNA markers and complex phenotypes
Kelly Stewart, PhD
- Health Potential (DNA-testing for complex chronic diseases)
- Sport Potential (DNA-testing for endurance sports)
- Phenoxx (DNA-testing for skin phenotypes)
G2: Consumer Genetics (Kelly Stewart)
Last 5 publications
- Weyerstrass, J., et al., Nine genetic polymorphisms associated with power athlete status - A Meta-Analysis. J Sci Med Sport, 2018. 21(2): p. 213-220.
- Stewart, K.F.J., et al., Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis. J Community Genet, 2018. 9(1): p. 1-18.
- Stewart, K.F.J., et al., Stages of behavioural change after direct-to-consumer disease risk profiling: study protocol of two integrated controlled pragmatic trials. Trials, 2018. 19(1): p. 240.
- Stewart, K.F.J., et al., Factors Associated with Acceptability, Consideration and Intention of Uptake of Direct-To-Consumer Genetic Testing: A Survey Study. Public Health Genomics, 2018: p. 1-8.
- Lipunova, N., et al., Gene-environment interaction with smoking on non muscle invasive bladder cancer size at the time of diagnosis. Genetic Epidemiology, 2018. 42(7): p. 714-714.